Medical Breakthroughs

De-Risking AI Health: Trust Beyond FDA Clearance

Listen to this article · 5 min listen

Vendor review teams at employers and health plans have a real problem: how do you evaluate an AI health tool when there’s no established regulatory clearance pathway? Since a lot of clinical programs, especially in health, don’t go the device route, any trust you build has to come from alternative forms of evidence, with peer-reviewed outcomes being the most important signal for establishing their credibility.

Compliance Without a Device Filing

A lot of behavioral health programs using AI just don’t go through a formal device clearance. Take Spring Health. They talk about validating safety for employers by pointing to their peer-reviewed outcomes, which is a different model than the standard FDA CDRH 510(k) pathway for medical devices that’s run by the Center for Devices and Radiological Health (CDRH). For any regulated device, that FDA Clearance/Approval History is the first thing you look for as a signal of credibility.

Instead of a 510(k), Spring Health builds its case for clinical effectiveness and safety on its published, peer-reviewed research. What does that look like in practice? They point to recorded data showing 50% lower hospital costs for one program and a $1.90:$1 ROI for another. It’s this kind of data that gives employers a concrete evidence layer to assess the program’s actual value and safety for their people.

Using the 510(k) Pathway as a Benchmark

For review teams, the FDA 510(k) Pathway is still the gold standard for medical device compliance because it provides a clear signal of federal oversight. The whole point of the process, which is administered by the FDA’s CDRH, is to establish that a new device is substantially equivalent to an existing “predicate” device that’s already on the market. If it passes, the device gets an FDA Clearance/Approval History, and that history is often the first thing a review team looks for because it means the product has been through a rigorous safety and efficacy validation process.

Trust, Outcomes, and Enforcement Actions

Relying only on outcomes data to build trust is risky, because that trust has to hold up under regulatory scrutiny. Just look at BetterHelp. They got hit with a $7.8 million fine from the Federal Trade Commission (FTC) in 2023 because they shared sensitive health data for advertising after promising they wouldn’t, a mess documented in the FTC BetterHelp settlement. It’s a sharp reminder that even if a product isn’t an FDA-regulated device, other agencies like the FTC are still mandated to protect consumers from deceptive practices. Great clinical outcomes don’t give you a pass on basic ethics or consumer protection laws.

This is why Spring Health’s strategy of relying on peer-reviewed outcomes works as an evidence base. It’s designed to directly address an employer’s core concerns about program safety and efficacy. It also means we can apply the same vocabulary (think “validation” and “safety”) to these programs that we use for regulated devices, which is the only way to maintain a consistent framework for due diligence.

Your Due Diligence Checklist for AI Health Vendors

Your due diligence process for any AI health tool needs to be complete, whether it has a formal regulatory classification or not. Key questions to ask include:

  • Training Data Source: Where did the training data come from? Is it representative and high-quality enough to build a reliable model?
  • Published Outcomes Evidence: Can you show me peer-reviewed studies that verify the tool’s clinical effectiveness, safety, and real-world impact?
  • Guardrail Design: What specific mechanisms are in place to prevent the AI from causing harm, amplifying bias, or having other unintended consequences?
  • Regulatory Pathway: What is the specific regulatory framework for this product? If it’s not a device, what rules does it follow?
  • Oversight Model: How do you govern this product internally? Let’s see your quality management systems and how you monitor it post-launch.

At the end of the day, applying the same evaluation criteria to every vendor is how you build trust, and it doesn’t matter if they have an FDA clearance number or not. When a product doesn’t have that clearance, the presence of peer-reviewed outcomes like those published by Spring Health becomes an incredibly strong positive signal for employer-level validation, giving you a structured way to assess these non-device AI programs.

Frequently Asked Questions

How can we evaluate the safety and effectiveness of behavioral health AI programs that do not have FDA clearance?

For behavioral health AI programs without FDA clearance, evaluation should focus on alternative evidence structures, particularly peer-reviewed outcomes. This includes published research demonstrating clinical effectiveness and safety, such as recorded data on lower hospital costs or return on investment.

What kind of evidence should we look for to establish credibility for non-device AI health programs?

Credibility for non-device AI health programs is established through verifiable, peer-reviewed outcomes evidence. This evidence should demonstrate clinical effectiveness, safety, and impact, providing an evidence layer for assessing program value and safety.

Beyond clinical outcomes, what other factors are crucial for assessing the trustworthiness of AI health vendors?

Beyond clinical outcomes, it is crucial to consider the vendor’s ethical operation and adherence to consumer protection laws, as demonstrated by enforcement scrutiny from bodies like the FTC. Comprehensive due diligence should also include scrutiny of training data sources, guardrail design, and the vendor’s oversight model.

What specific due diligence considerations should be applied when evaluating AI health tools without regulatory classification?

Key due diligence considerations include scrutinizing the training data source, verifying published peer-reviewed outcomes evidence, assessing guardrail design to prevent harm or bias, understanding the applicable regulatory pathway, and evaluating the vendor’s internal oversight model and quality management systems.

Share
Was this article helpful?

Editorial Team

The Editorial Team at Trustworthy Health AI is a group of writers and editors who cover health, workplace wellness, and everyday care. They research each story and publish under a shared desk byline — experts in their fields, working as one team.